Avanos Medical (NYSE:AVNS) Shares Gap Down – Here’s Why

Avanos Medical, Inc. (NYSE:AVNS) shares gapped down prior to trading on Tuesday . The stock had previously closed at $15.23, but opened at $14.21. Avanos Medical shares last traded at $13.5510, with a volume of 122,699 shares trading hands.

Analysts Set New Price Targets

AVNS has been the subject of several analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Avanos Medical in a report on Monday, December 22nd. Wall Street Zen upgraded Avanos Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Finally, Zacks Research upgraded shares of Avanos Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, January 26th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Avanos Medical has a consensus rating of “Reduce”.

Avanos Medical Stock Up 1.6%

The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.36 and a current ratio of 2.15. The business has a 50 day simple moving average of $12.95 and a 200-day simple moving average of $12.06. The firm has a market capitalization of $677.50 million, a price-to-earnings ratio of -9.27 and a beta of 1.09.

Avanos Medical (NYSE:AVNS) last issued its quarterly earnings data on Tuesday, February 24th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.05. Avanos Medical had a positive return on equity of 5.47% and a negative net margin of 10.40%.The firm had revenue of $180.90 million during the quarter, compared to the consensus estimate of $174.70 million. During the same period last year, the company earned $0.43 EPS. The company’s quarterly revenue was up .7% on a year-over-year basis. Avanos Medical has set its FY 2026 guidance at 0.900-1.100 EPS. On average, equities analysts expect that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Institutional Trading of Avanos Medical

Several institutional investors and hedge funds have recently bought and sold shares of AVNS. Alpine Global Management LLC acquired a new position in Avanos Medical in the 4th quarter valued at $177,000. Corient Private Wealth LLC purchased a new stake in Avanos Medical during the fourth quarter worth $234,000. Vident Advisory LLC acquired a new stake in Avanos Medical in the 4th quarter valued at about $585,000. State of Tennessee Department of Treasury increased its stake in shares of Avanos Medical by 50.0% during the 4th quarter. State of Tennessee Department of Treasury now owns 41,405 shares of the company’s stock worth $465,000 after purchasing an additional 13,799 shares in the last quarter. Finally, EP Wealth Advisors LLC acquired a new position in shares of Avanos Medical in the fourth quarter worth $201,000. Hedge funds and other institutional investors own 95.17% of the company’s stock.

About Avanos Medical

Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company’s products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.

In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.